3 Results for "

CDK8/19-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CDK8/19-IN-1" in MCE Product Catalog:

Cat. No.: HY-111427
CAS No.: 1818427-07-4
Purity:  98.03%
Target:  

CDK

Research Areas:  

Cancer

CDK8/19-IN-1 is a potent, selective and oral bioavailable CDK8/19 dual inhibitor, with IC50s of 0.46 nM, 0.99 nM and 270 nM for CDK8, CDK19 and CDK9, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122586
CAS No.: 642008-81-9
Purity:  99.56%
Target:  

CDK Interleukin Related

Research Areas:  

Inflammation/Immunology

BRD6989, an analog of the natural product cortistatin A (dCA), inhibits CDK8 and upregulates IL-10. BRD6989 selectively binds a complex of CDK8 with an IC50 of ~200 nM. BRD6989 inhibits the kinase activity of recombinant CDK8 or CDK19 complexes .
loading...
    loading...
Cat. No.: HY-111427R
CAS No.: 1818427-07-4
Target:  

Reference Standards CDK

Research Areas:  

Cancer

CDK8/19-IN-1 (Standard) is the analytical standard of CDK8/19-IN-1 (HY-111427). This product is intended for research and analytical applications. CDK8/19-IN-1 is a potent, selective and oral bioavailable CDK8/19 dual inhibitor, with IC50s of 0.46 nM, 0.99 nM and 270 nM for CDK8, CDK19 and CDK9, respectively.
loading...
    loading...